3rd Circ. Rejects Rehearing Bid From Niaspan Buyers
The Third Circuit on Monday refused a rehearing bid from Niaspan buyers accusing AbbVie Inc. and Teva Pharmaceuticals Ltd. of scheming to delay a generic version of the cholesterol drug, after an...To view the full article, register now.
Already a subscriber? Click here to view full article